March 20th 2025
Clinical characteristics were associated with different survival outcomes in patients treated with immune checkpoint inhibitor–based therapy.
The CDC has asked local and state health officials to maintain peak-season flu surveillance operation levels over the summer to watch for any signs of human-to-human spread of the H5N1 bird flu virus; the drug industry’s top lobbying group faced thorough questioning at a Senate Judiciary Committee hearing about the impact of patent system abuse on high prescription drug prices; FDA staff reviewers have raised concerns that Guardant Health’s colorectal cancer (CRC) blood test may fail to detect precancerous tumors.
Read More
Ultraprocessed Foods, Ice Cream Associated With Mortality in CRC Survivors
April 9th 2024Among patients who have survived colorectal cancer (CRC), there was an association between increased mortality due to CRC or cardiovascular disease and higher intake of ice cream and ultraprocessed foods.
Read More
Disease-Free, Overall Survival Lower in Patients With CRC Treated With PE, CRS/HIPEC
March 14th 2024Patients with stage IV colorectal cancer (CRC) had lower overall and disease-free survival if they had a pelvic exenteration (PE) or cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).
Read More
Bundling Interventions to Promote CRC, SDOH Screenings Found Feasible, Effective
February 14th 2024Combining interventions to encourage screenings for colorectal cancer (CRC) and social determinants of health (SDOH) was found to improve screening rates in CRC without decreasing rates of screenings for SDOH.
Read More